section name header

Pronunciation

GLI-ser-in

Classifications

Therapeutic Classification: antiglaucoma agents, laxatives

Pharmacologic Classification: osmotics

Indications

REMS


Action

  • Draws water into the lumen of the colon.
  • Osmotically draws water from extravascular spaces, including the eye, into intravascular compartment.
Therapeutic effects:
  • Relief of constipation.
  • Reduction of corneal edema.

Pharmacokinetics

Absorption: Not significantly absorbed from colonic mucosa.

Distribution: Remains in the intravascular space.

Metabolism/Excretion: 80% metabolized by the liver, 10–20% metabolized by the kidneys.

Half-Life: 30–45 min.

Time/Action Profile

ROUTEONSETPEAKDURATION
Rect (laxative effect)unknown15–30 minunknown
Ophth (reduced corneal swelling)unknownunknown3–4 hr



Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

F and E: dehydration

GI: diarrhea, nausea, cramping, vomiting

Neuro: headache, confusion

Misc: thirst

Interactions

Drug-drug:

Route/Dosage

Laxative

Reduction of Corneal Edema

Availability

(Generic available)

Assessment

Lab Test Considerations:

Implementation

Patient/Family Teaching

Evaluation/Desired Outcomes

US Brand Names

Fleet Babylax, Sani-Supp

Code

NDC Code